REGISTERED NUMBER: |
Strategic Report, Director's Report and |
Audited Financial Statements for the Year Ended 31 March 2024 |
for |
Amvale Medical Transport Limited |
REGISTERED NUMBER: |
Strategic Report, Director's Report and |
Audited Financial Statements for the Year Ended 31 March 2024 |
for |
Amvale Medical Transport Limited |
Amvale Medical Transport Limited (Registered number: 04502825) |
Contents of the Financial Statements |
for the Year Ended 31 March 2024 |
Page |
Company Information | 1 |
Strategic Report | 2 |
Director's Report | 4 |
Report of the Independent Auditors | 6 |
Income Statement | 10 |
Other Comprehensive Income | 11 |
Balance Sheet | 12 |
Statement of Changes in Equity | 13 |
Notes to the Financial Statements | 14 |
Amvale Medical Transport Limited |
Company Information |
for the Year Ended 31 March 2024 |
DIRECTOR: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
INDEPENDENT AUDITORS: |
117 - 119 Cleethorpe Road |
Grimsby |
North East Lincs |
DN31 3ET |
Amvale Medical Transport Limited (Registered number: 04502825) |
Strategic Report |
for the Year Ended 31 March 2024 |
PRINCIPAL ACTIVITY |
The principal activity of the company is the provision of ambulance transport, medical courier and SEN transport services |
Our operating offices are still located in Grimsby and Scunthorpe (Head office) and our sister company Amvale Scotland Ltd in Glasgow . |
The business operates within the CQC regulatory regime where applicable and as a business we are ISO 9001:2015 accredited, a Qualsafe approved training centre, Cyber Essentials Certified and Disability Confident Committed. |
The company is proud to work alongside its customers and to have introduced enhanced & bespoke services which have led to a reduction of turnaround times and operating costs for the customer and a greatly improved service user experience. |
REVIEW OF BUSINESS |
The results of the company as set out herein show turnover increasing from £15.65m FYE 31.3.23 to £16.7m 31.3.24. |
The company is always actively seeking new opportunities where we can provide enhanced service capabilities and cost benefits to our customers. |
The company has been successful with competitive tenders for schools transport resulting in a number of secured contracts that will assist in providing stability over the coming 3-5 years. |
Business Performance |
Over the course of the reported financial year the business continued to provide a high quality service across its spectrum of operations and this is borne out from service user and customer satisfaction surveys. |
Our business challenges are not unlike those faced by many SMEs in the wider economy , rising costs, compliancy costs, tax burdens borne by businesses, employment related costs to name but a few. |
It is envisaged that taxation & supply costs will continue to rise over the coming year. |
The business continues with its cost monitoring programmes which have provided improved cost control & tangible cost reductions. |
Investment in and increased use of technology is improving data reporting, providing operational efficiency benefits, reducing transactional processing costs and increasing productivity in back office functions. |
Debt ratio reduced from 0.43 to 0.37 |
ROCE decreased from 24.4% to 14.6% |
Current ratio increased from 2.59 to 2.82 |
Comparing turnover and costs for 2024 and 2023 and ignoring profit from asset disposals as a reduction in costs, ignoring other income, adjusting for bad debts in turnover, including depreciation and ignoring exceptional items leads to a trading turnover increase of 8.1% and OPEX increase of 5.3% (minus 5.3%) and therefore a JAWS ratio of +2.8%. Jaws ratio is defined as the difference between the percentage growth in turnover and the percentage growth in expenses. |
Energy efficiency actions |
At year end the number of vehicles that were compliant to EURO6 made up 89% of the total fleet of 361 vehicles up from 81% FYE 2022 . Amvale Medical Transport is all too aware that all businesses generate an environmental impact. |
We aim to minimise our impact where possible and we have introduced various initiatives to support our aims which are: |
Amvale Medical Transport Limited (Registered number: 04502825) |
Strategic Report |
for the Year Ended 31 March 2024 |
- Working with our ESOS partner to better understand areas in which we can improve (the business is currently undertaking an ESOS Phase 3 assessment). |
- Following the NHS Non emergency patient transport decarbonisation timeline which recommends that from 2023 50% of vehicles used to deliver contracts are of the latest emissions standards Ultra low emissions vehicles (ULEV) or zero emissions vehicles (ZEV) 75% from 2026 |
- Introduction of led lights in offices and auto sensing switches in communal areas |
- Monitoring and reporting of vehicle idling times |
- Reminder to all to think before they print and place greater emphasis on using electronic means of storing and sharing data rather than using paper wherever possible |
- Driver performance scoring. This includes monitoring various areas of driver behaviour and providing awareness and retraining as required |
Employees |
The board would like to thank all employees for their continued efforts and support to the company, our customers and the service users themselves. |
We continue to upskill our employees by way of ad hoc training as well as professional and accredited membership training and we have increasingly utilised the apprenticeship levy scheme to support both internal upskilling and to provide accredited training to new employees. |
Regular two way communication with employees takes place in a formal manner through meetings held between the general manager, directors and heads of departments and a minimum of 3 ; maximum 6 employees on a rotating basis to ensure that the business obtain input from a wide base of employees. |
The meeting minutes and actions are distributed to all employees within the operating division and followed through by all parties to ensure that the common purpose of providing a safe, pleasant, fair and engaged environment for all employees to work is at the forefront of the business. |
We provide a number of channels to keep employees informed and engaged such as site tv monitors, social media and we are working towards producing a quarterly company gazette. |
ON BEHALF OF THE BOARD: |
Amvale Medical Transport Limited (Registered number: 04502825) |
Director's Report |
for the Year Ended 31 March 2024 |
The director presents his report with the financial statements of the company for the year ended 31 March 2024. |
PRINCIPAL ACTIVITY |
The principal activity of the company in the year under review was that of the provision of medical and school transport services. |
DIVIDENDS |
An interim dividend of £ |
The total distribution of dividends for the year ended 31 March 2024 will be £ |
DIRECTOR |
EMPLOYEES |
The company places considerable value on the involvement of its employees and has continued to keep them informed on matters affecting them as employees and on the various factors affecting the performance of the company. This has been achieved through formal and informal meetings, electronic communication and updates and the annual financial statements. |
Applications for employment by disabled persons are always fully considered, bearing in mind the abilities of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment with the company continues and that appropriate support and training is provided. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees. |
Overall the company policy for recruitment, selection, remuneration, training, development and promotion are designed to ensure that eligibility is considered on the basis of the aptitudes and abilities of the person concerned and that nobody receives less favourable treatment on any grounds. |
STATEMENT OF DIRECTOR'S RESPONSIBILITIES |
The director is responsible for preparing the Strategic Report, the Director's Report and the financial statements in accordance with applicable law and regulations. |
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to: |
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
Amvale Medical Transport Limited (Registered number: 04502825) |
Director's Report |
for the Year Ended 31 March 2024 |
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. |
AUDITORS |
The auditors, Haines Watts, Chartered Accountants will be proposed for re-appointment at the forthcoming Annual General Meeting. |
ON BEHALF OF THE BOARD: |
Report of the Independent Auditors to the Members of |
Amvale Medical Transport Limited |
Opinion |
We have audited the financial statements of Amvale Medical Transport Limited (the 'company') for the year ended 31 March 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
In our opinion the financial statements: |
- | give a true and fair view of the state of the company's affairs as at 31 March 2024 and of its profit for the year then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
Basis for opinion |
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
Conclusions relating to going concern |
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report. |
Other information |
The director is responsible for the other information. The other information comprises the information in the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon. |
Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
Opinions on other matters prescribed by the Companies Act 2006 |
In our opinion, based on the work undertaken in the course of the audit: |
- | the information given in the Strategic Report and the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
- | the Strategic Report and the Director's Report have been prepared in accordance with applicable legal requirements. |
Report of the Independent Auditors to the Members of |
Amvale Medical Transport Limited |
Matters on which we are required to report by exception |
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Director's Report. |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of director's remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit. |
Responsibilities of director |
As explained more fully in the Statement of Director's Responsibilities set out on page four, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so. |
Report of the Independent Auditors to the Members of |
Amvale Medical Transport Limited |
Auditors' responsibilities for the audit of the financial statements |
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
Through discussion with management and those charged with governance we gained an understanding of the legal and regulatory framework applicable to the entity and the industry in which it operates, and considered the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud. During the engagement team briefing we communicated the identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit. |
We focused on laws and regulations that could give rise to a material misstatement in the financial statements, including, but not limited to, UK GAAP (FRS102), the Companies Act 2006, tax legislations and CQC regulations. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items. |
We evaluated management's incentives and opportunities for fraudulent manipulations of the financial statements (including risk of override of controls) and determined that the principal risks were related to management bias in accounting estimates. |
Audit procedures undertaken in response to the potential risk relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of: |
- enquiries of management and those charged with governance as to whether the entity complies with such laws and regulations; |
- enquiries with the same concerning any actual or potential litigation claims; |
- reviewed risk of management override; |
- review of journal entries posted with unusual account combinations or posted by senior management; |
- reviewing accounting estimates for bias; |
- performance of analytical review to identify unexpected movements in account balances which may be indicative of fraud; |
- agreeing financial statement disclosures to underlying supporting documentation. |
The likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, |
the effectiveness of the entity's controls, the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK). |
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
Report of the Independent Auditors to the Members of |
Amvale Medical Transport Limited |
Use of our report |
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
for and on behalf of |
117 - 119 Cleethorpe Road |
Grimsby |
North East Lincs |
DN31 3ET |
Amvale Medical Transport Limited (Registered number: 04502825) |
Income Statement |
for the Year Ended 31 March 2024 |
31.3.24 | 31.3.23 |
Notes | £ | £ |
TURNOVER | 3 |
Cost of sales |
GROSS PROFIT |
Administrative expenses |
OPERATING PROFIT | 5 |
Exceptional items | 6 |
1,203,723 | 1,820,289 |
Interest receivable and similar income |
1,322,960 | 1,821,777 |
Interest payable and similar expenses | 7 |
PROFIT BEFORE TAXATION |
Tax on profit | 8 |
PROFIT FOR THE FINANCIAL YEAR |
Amvale Medical Transport Limited (Registered number: 04502825) |
Other Comprehensive Income |
for the Year Ended 31 March 2024 |
31.3.24 | 31.3.23 |
Notes | £ | £ |
PROFIT FOR THE YEAR |
OTHER COMPREHENSIVE INCOME | - | - |
TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
Amvale Medical Transport Limited (Registered number: 04502825) |
Balance Sheet |
31 March 2024 |
31.3.24 | 31.3.23 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 10 |
CURRENT ASSETS |
Stocks | 11 |
Debtors | 12 |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 13 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
14 |
( |
) |
( |
) |
PROVISIONS FOR LIABILITIES | 18 | ( |
) | ( |
) |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 19 |
Share premium | 20 |
Retained earnings | 20 |
SHAREHOLDERS' FUNDS |
The financial statements were approved by the director and authorised for issue on |
Amvale Medical Transport Limited (Registered number: 04502825) |
Statement of Changes in Equity |
for the Year Ended 31 March 2024 |
Called up |
share | Retained | Share | Total |
capital | earnings | premium | equity |
£ | £ | £ | £ |
Balance at 1 April 2022 |
Changes in equity |
Dividends | - | ( |
) | - | ( |
) |
Total comprehensive income | - | - |
Balance at 31 March 2023 |
Changes in equity |
Dividends | - | ( |
) | - | ( |
) |
Total comprehensive income | - | - |
Balance at 31 March 2024 |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements |
for the Year Ended 31 March 2024 |
1. | STATUTORY INFORMATION |
Amvale Medical Transport Limited is a |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Financial Reporting Standard 102 - reduced disclosure exemptions |
The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland": |
• | the requirements of Section 7 Statement of Cash Flows. |
Related party exemption |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
Significant judgements and estimates |
In applying the company's accounting policies set out below management is required to make certain estimates and judgements concerning the future. These judgements are regularly reviewed and updated as necessary. The estimates and judgements that have most significant effect on the amounts included in these financial statements are as follows: |
- Useful lives of plant and equipment |
Depreciation is provided so as to write down the assets to their residual values over their estimated useful lives as set out in the company's accounting policy. The selection of these estimated useful lives requires the exercise of management judgement. Useful lives are regularly reviewed and should management's assessment of useful lives shorten then depreciation charges in the financial statements would increase and carrying amounts of property, plant and equipment would reduce accordingly. |
- Trade debtors |
The company reviews the reconcilability of trade debtors and makes allowances for doubtful debts where considered appropriate. If there is evidence of impairment the carrying amount of the debtor is reduced to its recoverable amount. The impairment loss is recognised immediately in the income statement. |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, net of discounts, rebates, and value added tax and other sales taxes. Turnover includes revenue earned from the rendering of services. |
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract and based on the timing of the services performed. |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
2. | ACCOUNTING POLICIES - continued |
Tangible fixed assets |
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. The company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when the cost is incurred if the replacement part is expected to provide incremental future benefits to the company. The carrying amount of the replaced part is derecognised. |
Repairs and maintenance are charged to the income statement during the period in which they are incurred. |
Depreciation is provided to write off the cost, less estimated residual values, of all tangible fixed assets, except for freehold land, evenly over their expected useful lives. It is calculated at the following rates: |
Plant and machinery | - | 25% on reducing balance |
Motor vehicles | - | 20% on cost |
Fixtures and fittings | - | 15% on reducing balance |
Computer equipment | - | 25% on reducing balance |
Freehold Property | - | 2% on cost |
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. |
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the income statement. |
Stocks |
Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell, after making due allowance for obsolete and slow moving items. Cost is calculated on an average cost basis. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
2. | ACCOUNTING POLICIES - continued |
Hire purchase and leasing commitments |
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter. |
The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they are paid. |
Going concern |
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors therefore continue to adopt the going concern basis of accounting in preparing the financial statements. |
Impairment of assets |
At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised in profit or loss. |
If an impairment loss subsequently reverses, the carry amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss. |
3. | TURNOVER |
The turnover and profit before taxation are attributable to the one principal activity of the company. |
An analysis of turnover by class of business is given below: |
31.3.24 | 31.3.23 |
£ | £ |
4. | EMPLOYEES AND DIRECTORS |
31.3.24 | 31.3.23 |
£ | £ |
Wages and salaries |
Social security costs |
Other pension costs |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
4. | EMPLOYEES AND DIRECTORS - continued |
The average number of employees during the year was as follows: |
31.3.24 | 31.3.23 |
Management and administration | 17 | 22 |
Ambulance station and control staff | 12 | 12 |
Paramedics and technicians | 142 | 138 |
SEN staff | 328 | 306 |
31.3.24 | 31.3.23 |
£ | £ |
Directors' remuneration |
Directors' pension contributions to money purchase schemes |
The number of directors to whom retirement benefits were accruing was as follows: |
Money purchase schemes |
5. | OPERATING PROFIT |
The operating profit is stated after charging/(crediting): |
31.3.24 | 31.3.23 |
£ | £ |
Hire of plant and machinery |
Other operating leases |
Depreciation - owned assets |
Depreciation - assets on hire purchase contracts |
Profit on disposal of fixed assets | ( |
) | ( |
) |
Auditors' remuneration |
Auditors' remuneration for non audit work |
6. | EXCEPTIONAL ITEMS |
31.3.24 | 31.3.23 |
£ | £ |
Exceptional items |
The exceptional item in the prior period relates to the successful resolution of a longstanding input tax reclaim. |
7. | INTEREST PAYABLE AND SIMILAR EXPENSES |
31.3.24 | 31.3.23 |
£ | £ |
Bank loan interest |
Hire purchase |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
8. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit for the year was as follows: |
31.3.24 | 31.3.23 |
£ | £ |
Current tax: |
UK corporation tax |
Deferred tax |
Tax on profit |
Reconciliation of total tax charge included in profit and loss |
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below: |
31.3.24 | 31.3.23 |
£ | £ |
Profit before tax |
Profit multiplied by the standard rate of corporation tax in the UK of (2023 - |
Effects of: |
Expenses not deductible for tax purposes |
Depreciation in excess of capital allowances |
Prior year adjustment | - | (62,953 | ) |
Corporation tax interest | - | (2,628 | ) |
Total tax charge | 344,328 | 284,177 |
9. | DIVIDENDS |
31.3.24 | 31.3.23 |
£ | £ |
Interim |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
10. | TANGIBLE FIXED ASSETS |
Fixtures |
Freehold | Plant and | and |
property | machinery | fittings |
£ | £ | £ |
COST |
At 1 April 2023 |
Additions |
Disposals |
At 31 March 2024 |
DEPRECIATION |
At 1 April 2023 |
Charge for year |
Eliminated on disposal |
At 31 March 2024 |
NET BOOK VALUE |
At 31 March 2024 |
At 31 March 2023 |
Motor | Computer |
vehicles | equipment | Totals |
£ | £ | £ |
COST |
At 1 April 2023 |
Additions |
Disposals | ( |
) | ( |
) |
At 31 March 2024 |
DEPRECIATION |
At 1 April 2023 |
Charge for year |
Eliminated on disposal | ( |
) | ( |
) |
At 31 March 2024 |
NET BOOK VALUE |
At 31 March 2024 |
At 31 March 2023 |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
10. | TANGIBLE FIXED ASSETS - continued |
Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
Motor |
vehicles |
£ |
COST |
At 1 April 2023 |
Additions |
Transfer to ownership | (825,841 | ) |
At 31 March 2024 |
DEPRECIATION |
At 1 April 2023 |
Charge for year |
Transfer to ownership | (1,794,905 | ) |
At 31 March 2024 |
NET BOOK VALUE |
At 31 March 2024 |
At 31 March 2023 |
11. | STOCKS |
31.3.24 | 31.3.23 |
£ | £ |
Stocks |
12. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.24 | 31.3.23 |
£ | £ |
Trade debtors |
Amounts owed by group undertakings |
Other debtors |
Director's loan account | 727,097 | 128,940 |
Tax |
Prepayments |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
13. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.24 | 31.3.23 |
£ | £ |
Bank loans and overdrafts (see note 15) |
Hire purchase contracts (see note 16) |
Trade creditors |
Corporation tax |
Social security and other taxes |
VAT | 326,705 | 94,895 |
Other creditors |
Accrued expenses |
14. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
31.3.24 | 31.3.23 |
£ | £ |
Bank loans (see note 15) |
Hire purchase contracts (see note 16) |
15. | LOANS |
An analysis of the maturity of loans is given below: |
31.3.24 | 31.3.23 |
£ | £ |
Amounts falling due within one year or on demand: |
Bank loans |
Amounts falling due between one and two years: |
Bank loans - 1-2 years |
Amounts falling due between two and five years: |
Bank loans - 2-5 years |
The terms of repayment and interest rates for debts falling due after more than 5 years are by monthly instalment based on a fixed interest rate of 2.46%. |
16. | LEASING AGREEMENTS |
Minimum lease payments under hire purchase fall due as follows: |
31.3.24 | 31.3.23 |
£ | £ |
Net obligations repayable: |
Within one year |
Between one and five years |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
17. | SECURED DEBTS |
The following secured debts are included within creditors: |
31.3.24 | 31.3.23 |
£ | £ |
Hire purchase contracts | 1,774,913 | 1,990,768 |
Amounts outstanding on hire purchase contracts are secured against the related asset acquired. |
The bank loan is secured against a fixed and floating charge over the company's assets. |
18. | PROVISIONS FOR LIABILITIES |
31.3.24 | 31.3.23 |
£ | £ |
Deferred tax | 208,226 | 147,566 |
Deferred |
tax |
£ |
Balance at 1 April 2023 |
Provided during year |
Balance at 31 March 2024 |
19. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.3.24 | 31.3.23 |
value: | £ | £ |
Ordinary | £1 | 20,000 | 20,000 |
20. | RESERVES |
Retained | Share |
earnings | premium | Totals |
£ | £ | £ |
At 1 April 2023 | 5,872,541 |
Profit for the year |
Dividends | ( |
) | ( |
) |
At 31 March 2024 | 6,597,147 |
21. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES |
31.3.24 | 31.3.23 |
£ | £ |
Balance owing from directors | 727,096 | 128,940 |
Maximum outstanding balance during the year | 727,096 | 215,191 |
Interest charged at the official rate of interest | 8,108 | 1,488 |
Amvale Medical Transport Limited (Registered number: 04502825) |
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2024 |
22. | RELATED PARTY DISCLOSURES |
Information about related party transactions and outstanding balances are outlined below: |
31.3.24 | 31.3.23 |
£ | £ |
Sales made to related parties | 919,413 | 319,092 |
Purchases made from related parties | 274,571 | 720,187 |
Amounts owing from related parties | 638.200 | 577,460 |
Outstanding balances due to/from the company are unsecured and no formal agreement is in place. |
The related parties are companies of which M J Godfrey is also a director or a shareholder. |
23. | ULTIMATE CONTROLLING PARTY |
The controlling party is AMT2 Limited. |
The ultimate controlling party is |